In this context, due both to the tumor immunosuppressive environment and to prolonged exposure to tumor antigens, high PD-1 expression may be detected on tumor-infiltrating lymphocytes (TILs), which is associated with defects in immune cell function and the expression of other inhibitory receptors [11,12]. The gene discussed is PDCD1; the disease is neoplasm.